Sign in

CIK 0000882796

  • Large accelerated filer

BIOCRYST PHARMACEUTICALS INC

Sign in to watch
Ticker
BCRX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
621413174
Phone
+1 919-859-1302
Business address
4505 EMPEROR BOULEVARD, SUITE 200, DURHAM, NC, 27703
  1. 4 Grant or award Director acquired 12,500 shares (grant or award)
  2. 4 Grant or award Director acquired 12,500 shares (grant or award)
  3. 4 Grant or award Director acquired 523 shares (grant or award)
  4. 4 Grant or award Director acquired 333 shares (grant or award)
  5. 4 Grant or award Director acquired 1,866 shares (grant or award)
  6. 3 Insider Initial Statement of Ownership
  7. 4 Shares withheld for taxes Chief R&D Officer gave up 7,525 shares (to pay taxes)
  8. 4 Grant or award Director acquired 653 shares (grant or award)
  9. 4 Shares withheld for taxes Chief Commercial Officer gave up 2,461 shares (to pay taxes)
  10. 4 Shares withheld for taxes Chief R&D Officer gave up 6,096 shares (to pay taxes)
  11. 4 Shares withheld for taxes Chief Financial Officer gave up 2,461 shares (to pay taxes)
  12. 4 Shares withheld for taxes Chief Legal Officer gave up 2,461 shares (to pay taxes)
  13. 4 Shares withheld for taxes President & CEO gave up 14,010 shares (to pay taxes)
  14. 4 Shares withheld for taxes Chief Commercial Officer gave up 8,251 shares (to pay taxes)
  15. 4 Shares withheld for taxes President & CEO gave up 27,525 shares (to pay taxes)
  16. 4 Shares withheld for taxes Chief Legal Officer gave up 8,613 shares (to pay taxes)
  17. 4 Shares withheld for taxes Chief Financial Officer gave up 7,890 shares (to pay taxes)
  18. 4 Shares withheld for taxes Chief R&D Officer gave up 7,150 shares (to pay taxes)
  19. 4 Planned sale Director sold 7,000 shares at $7.54 ($52,780)
  20. 4 Grant or award Director acquired 750 shares (grant or award)

Page 4 of 49 · 965 filings